This insight may provide a new means for pharmacological regulation of KRIT1 localization, which would be beneficial in studying its functions within specific subcellular compartments, as well as in the development of novel targeted therapeutic strategies for CCM disease. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.